Skip to content
Search

Latest Stories

Community pharmacy patient safety group appoints new leadership

Community pharmacy patient safety group appoints new leadership
 As community pharmacy expands services, the new CPPSG leaders to bolster patient safety

Jackie Giltrow and Jose Moss have been appointed as Chair and Vice-Chair of the Community Pharmacy Patient Safety group, respectively, bringing with them a wealth of experience and expertise in pharmacy practice.

Supported by the National Pharmacy Association (NPA) and hosted by the Company Chemists’ Association (CCA), the CPPSG serves as a collaborative platform for large community pharmacy organisations to openly share and learn from each other's experiences.


A CPPSG Chair now, Jackie Giltrow, Clinical Governance Lead at Paydens Limited is a seasoned pharmacist and expert in risk management and patient safety.

With nine years of experience as a member of the CPPSG, Giltrow's appointment represents a continuation of her longstanding dedication to advancing patient safety initiatives within community pharmacy settings.

She expressed her enthusiasm for the opportunity, stating, "I am delighted to have been appointed as Chair of the Community Pharmacy Patient Safety Group."

"The Group is instrumental in promoting patient safety and driving improvements in community pharmacy."

Joining Giltrow in leadership is Jose Moss, who brings a wealth of knowledge in adverse incident management and regulatory governance.

As Vice-Chair, Moss is poised to leverage her extensive experience within Boots UK Limited as Deputy Superintendent Pharmacist to further strengthen the CPPSG's impact on patient safety initiatives.

"As community pharmacy continues to advance and provide more pharmacy services, it is essential that we work together across our organisations to prioritise patient safety in our work," Moss remarked.

The CPPSG, established in 2015 following an NHS alert recommending the identification of Medication Safety Officers (MSOs) within community pharmacy businesses, has since grown to encompass a diverse range of organisations.

With the recent addition of three new members, the group now comprises 21 organisations, underscoring its ongoing relevance and impact in promoting patient safety.

Dr. June Raine, Chief Executive Officer of the Medicines & Healthcare products Regulatory Agency (MHRA), commended the group's continued dedication to patient safety, stating:

"The Group is an invaluable asset not only in promoting patient safety in community pharmacy but in making a meaningful contribution, sharing and learning with the wider patient safety community."

The CPPSG plays an important role in discussing and disseminating learnings from patient safety incidents to foster a culture of transparency and continuous improvement in patient care.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less